BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dewidar B, Meyer C, Dooley S, Meindl-Beinker AN. TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019. Cells 2019;8:E1419. [PMID: 31718044 DOI: 10.3390/cells8111419] [Cited by in Crossref: 96] [Cited by in F6Publishing: 107] [Article Influence: 32.0] [Reference Citation Analysis]
Number Citing Articles
1 Jung HJ, Cho K, Kim SY, Seong JK, Oh SH. Ethanol extract of Pharbitis nil ameliorates liver fibrosis through regulation of the TGFβ1-SMAD2/3 pathway. J Ethnopharmacol 2022;294:115370. [PMID: 35568114 DOI: 10.1016/j.jep.2022.115370] [Reference Citation Analysis]
2 Liu T, Chen S, Xie X, Liu H, Wang Y, Qi S, Shi L, Zhou X, Zhang J, Wang S, Wang Y, Chen S, Dou S, Jiang X, Cui R, Jiang H. Soluble TREM-1, as a new ligand for the membrane receptor Robo2, promotes hepatic stellate cells activation and liver fibrosis. J Cell Mol Med 2021. [PMID: 34750987 DOI: 10.1111/jcmm.17033] [Reference Citation Analysis]
3 Huisman TM, Dieterich DT, Friedman SL. Experimental and Investigational Targeted Therapies for the Management of Fibrosis in NASH: An Update. J Exp Pharmacol 2021;13:329-38. [PMID: 33776490 DOI: 10.2147/JEP.S265286] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Nie X, Yu Q, Li L, Yi M, Wu B, Huang Y, Zhang Y, Han H, Yuan X. Kinsenoside Protects Against Radiation-Induced Liver Fibrosis via Downregulating Connective Tissue Growth Factor Through TGF-β1 Signaling. Front Pharmacol 2022;13:808576. [DOI: 10.3389/fphar.2022.808576] [Reference Citation Analysis]
5 da Silva Meirelles L, Marson RF, Solari MIG, Nardi NB. Are Liver Pericytes Just Precursors of Myofibroblasts in Hepatic Diseases? Insights from the Crosstalk between Perivascular and Inflammatory Cells in Liver Injury and Repair. Cells 2020;9:E188. [PMID: 31940814 DOI: 10.3390/cells9010188] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
6 Li S, Wang C, Zhang X, Su W. Cytochrome P450 Omega-Hydroxylase 4a14 Attenuates Cholestatic Liver Fibrosis. Front Physiol 2021;12:688259. [PMID: 34135776 DOI: 10.3389/fphys.2021.688259] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhang B, Meng F, Liu Y, Yuan Y, Wang J, Wu D, Cui Y, Zhang S, Guo H, Liang S, Wang W, Klos M, Morgenstern S, Liu Y, Sun L, Ma K, Liu X, Wang Y, Han J, Yang G, Zheng C, Li X, Zhou S, Ji C, Bai Q, Wang J, Liu L. Inhibition of TGFβ1 accelerates regeneration of fibrotic rat liver elicited by a novel two-staged hepatectomy. Theranostics 2021;11:4743-58. [PMID: 33754025 DOI: 10.7150/thno.52102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Park YJ, Jeon MS, Lee S, Kim JK, Jang TS, Chung KH, Kim KH. Anti-fibrotic effects of brevilin A in hepatic fibrosis via inhibiting the STAT3 signaling pathway. Bioorg Med Chem Lett 2021;41:127989. [PMID: 33794317 DOI: 10.1016/j.bmcl.2021.127989] [Reference Citation Analysis]
9 Yang M, Kimchi ET, Staveley-O'Carroll KF, Li G. Astaxanthin Prevents Diet-Induced NASH Progression by Shaping Intrahepatic Immunity. Int J Mol Sci 2021;22:11037. [PMID: 34681695 DOI: 10.3390/ijms222011037] [Reference Citation Analysis]
10 Wegrzyniak O, Rosestedt M, Eriksson O. Recent Progress in the Molecular Imaging of Nonalcoholic Fatty Liver Disease. Int J Mol Sci 2021;22:7348. [PMID: 34298967 DOI: 10.3390/ijms22147348] [Reference Citation Analysis]
11 Li YH, Shen S, Shao T, Jin MT, Fan DD, Lin AF, Xiang LX, Shao JZ. Mesenchymal stem cells attenuate liver fibrosis by targeting Ly6Chi/lo macrophages through activating the cytokine-paracrine and apoptotic pathways. Cell Death Discov 2021;7:239. [PMID: 34518510 DOI: 10.1038/s41420-021-00584-z] [Reference Citation Analysis]
12 Yao Y, Xia Z, Cheng F, Jang Q, He J, Pan C, Zhang L, Ye Y, Wang Y, Chen S, Su D, Su X, Cheng L, Shi G, Dai L, Deng H. Human placental mesenchymal stem cells ameliorate liver fibrosis in mice by upregulation of Caveolin1 in hepatic stellate cells. Stem Cell Res Ther 2021;12:294. [PMID: 34016164 DOI: 10.1186/s13287-021-02358-x] [Reference Citation Analysis]
13 Yin F, Mao LC, Cai QQ, Jiang WH. Effect of Hepatocyte Growth Factor-Transfected Human Umbilical Cord Mesenchymal Stem Cells on Hepatic Stellate Cells by Regulating Transforming Growth Factor-β1/Smads Signaling Pathway. Stem Cells Dev 2021;30:1070-81. [PMID: 34514810 DOI: 10.1089/scd.2021.0136] [Reference Citation Analysis]
14 Yang Z, Hong W, Zheng K, Feng J, Hu C, Tan J, Zhong Z, Zheng Y, Franco JL. Chitosan Oligosaccharides Alleviate H2O2-stimulated Granulosa Cell Damage via HIF-1α Signaling Pathway. Oxidative Medicine and Cellular Longevity 2022;2022:1-15. [DOI: 10.1155/2022/4247042] [Reference Citation Analysis]
15 Chhimwal J, Sharma S, Kulurkar P, Patial V. Crocin attenuates CCl4-induced liver fibrosis via PPAR-γ mediated modulation of inflammation and fibrogenesis in rats. Hum Exp Toxicol 2020;39:1639-49. [PMID: 32633567 DOI: 10.1177/0960327120937048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
16 Gong H, Fan Z, Yi D, Chen J, Li Z, Guo R, Wang C, Fang W, Liu S. Histidine kinase NME1 and NME2 are involved in TGF-β1-induced HSC activation and CCl4-induced liver fibrosis. J Mol Histol 2020;51:573-81. [PMID: 32860079 DOI: 10.1007/s10735-020-09906-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Wu Z, Wang J, Feng J, Ying L. MicroRNA-122-5p prevents proliferation and promotes apoptosis of hepatic stellate cells by suppressing the cellular-Abelsongene/histone deacetylases 2 pathway. Hum Exp Toxicol 2022;41:9603271221084672. [PMID: 35303413 DOI: 10.1177/09603271221084672] [Reference Citation Analysis]
18 Mao Y, Jacob V, Singal A, Lei S, Park MS, Lima MRN, Li C, Dhall S, Sathyamoorthy M, Kohn J. Exosomes Secreted from Amniotic Membrane Contribute to Its Anti-Fibrotic Activity. Int J Mol Sci 2021;22:2055. [PMID: 33669673 DOI: 10.3390/ijms22042055] [Reference Citation Analysis]
19 Wang T, Zhang C, Meng X, Zhu B, Wang S, Yuan W, Zhang S, Xu J, Zhang C. Long Noncoding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 in Extracellular Vesicles Promotes Hepatic Stellate Cell Activation, Liver Fibrosis and β-Catenin Signaling Pathway. Front Physiol 2022;13:792182. [DOI: 10.3389/fphys.2022.792182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Datfar T, Doulberis M, Papaefthymiou A, Hines IN, Manzini G. Viral Hepatitis and Hepatocellular Carcinoma: State of the Art. Pathogens 2021;10:1366. [PMID: 34832522 DOI: 10.3390/pathogens10111366] [Reference Citation Analysis]
21 Peng D, Fu M, Wang M, Wei Y, Wei X. Targeting TGF-β signal transduction for fibrosis and cancer therapy. Mol Cancer 2022;21. [DOI: 10.1186/s12943-022-01569-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
22 Feng Y, Dong H, Sun B, Hu Y, Yang Y, Jia Y, Jia L, Zhong X, Zhao R. METTL3/METTL14 Transactivation and m6A-Dependent TGF-β1 Translation in Activated Kupffer Cells. Cell Mol Gastroenterol Hepatol 2021;12:839-56. [PMID: 33992834 DOI: 10.1016/j.jcmgh.2021.05.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Li W, Yu X, Chen X, Wang Z, Yin M, Zhao Z, Zhu C. HBV induces liver fibrosis via the TGF-β1/miR-21-5p pathway. Exp Ther Med 2021;21:169. [PMID: 33456536 DOI: 10.3892/etm.2020.9600] [Reference Citation Analysis]
24 Chen H, Cai J, Wang J, Qiu Y, Jiang C, Wang Y, Wang Y, Yi C, Guo Lv, Pan L, Guan Y, Zheng J, Qiu D, Du C, Liu Q, Chen G, Yang Y, Xu Y, Xiang AP, Zhang Q. Targeting Nestin+ hepatic stellate cells ameliorates liver fibrosis by facilitating TβRI degradation. J Hepatol 2021;74:1176-87. [PMID: 33217494 DOI: 10.1016/j.jhep.2020.11.016] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
25 Oliva ME, Ingaramo P, Vega Joubert MB, Ferreira MDR, D'Alessandro ME. Effects of Salvia hispanica L. (chia) seed on blood coagulation, endothelial dysfunction and liver fibrosis in an experimental model of Metabolic Syndrome. Food Funct 2021;12:12407-20. [PMID: 34797360 DOI: 10.1039/d1fo02274a] [Reference Citation Analysis]
26 Li SW, Takahara T, Que W, Fujino M, Guo WZ, Hirano SI, Ye LP, Li XK. Hydrogen-rich water protects against liver injury in nonalcoholic steatohepatitis through HO-1 enhancement via IL-10 and Sirt 1 signaling. Am J Physiol Gastrointest Liver Physiol 2021;320:G450-63. [PMID: 33439102 DOI: 10.1152/ajpgi.00158.2020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
27 Chen Y, Fan Y, Guo DY, Xu B, Shi XY, Li JT, Duan LF. Study on the relationship between hepatic fibrosis and epithelial-mesenchymal transition in intrahepatic cells. Biomed Pharmacother 2020;129:110413. [PMID: 32570119 DOI: 10.1016/j.biopha.2020.110413] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
28 Voutilainen SH, Kosola SK, Lohi J, Jahnukainen T, Pakarinen MP, Jalanko H. Expression of fibrosis-related genes in liver allografts: Association with histology and long-term outcome after pediatric liver transplantation. Clin Transplant 2021;:e14373. [PMID: 34043847 DOI: 10.1111/ctr.14373] [Reference Citation Analysis]
29 Liu XY, Li D, Li TY, Wu Y, Piao JS, Piao MG. Vitamin A - modified Betulin polymer micelles with hepatic targeting capability for hepatic fibrosis protection. European Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.ejps.2022.106189] [Reference Citation Analysis]
30 Zhang K, Zhang M, Luo Z, Wen Z, Yan X. The dichotomous role of TGF-β in controlling liver cancer cell survival and proliferation. J Genet Genomics 2020;47:497-512. [PMID: 33339765 DOI: 10.1016/j.jgg.2020.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Zhang L, Gao J, Zhou D, Wang X, Li J, Wang J, Chen H, Xie X, Chen T. Profiles of messenger RNAs and MicroRNAs in hypoxia-induced hepatic stellate cells. Ann Transl Med 2021;9:1451. [PMID: 34734003 DOI: 10.21037/atm-21-4215] [Reference Citation Analysis]
32 Zhou X, Liang Z, Qin S, Ruan X, Jiang H. Serum-derived miR-574-5p-containing exosomes contribute to liver fibrosis by activating hepatic stellate cells. Mol Biol Rep 2021. [PMID: 34843038 DOI: 10.1007/s11033-021-07008-2] [Reference Citation Analysis]
33 Kataoka S, Umemura A, Okuda K, Taketani H, Seko Y, Nishikawa T, Yamaguchi K, Moriguchi M, Kanbara Y, Arbiser JL, Shima T, Okanoue T, Itoh Y. Honokiol Acts as a Potent Anti-Fibrotic Agent in the Liver through Inhibition of TGF-β1/SMAD Signaling and Autophagy in Hepatic Stellate Cells. Int J Mol Sci 2021;22:13354. [PMID: 34948151 DOI: 10.3390/ijms222413354] [Reference Citation Analysis]
34 Awan T, Babendreyer A, Wozniak J, Alvi AM, Sterzer V, Cook L, Bartsch JW, Liedtke C, Yildiz D, Ludwig A. Expression of the Metalloproteinase ADAM8 Is Upregulated in Liver Inflammation Models and Enhances Cytokine Release In Vitro. Mediators Inflamm 2021;2021:6665028. [PMID: 33814981 DOI: 10.1155/2021/6665028] [Reference Citation Analysis]
35 Khanam A, Saleeb PG, Kottilil S. Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured? Cells 2021;10:1097. [PMID: 34064375 DOI: 10.3390/cells10051097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Xie X, Lv H, Liu C, Su X, Yu Z, Song S, Bian H, Tian M, Qin C, Qi J, Zhu Q. HBeAg mediates inflammatory functions of macrophages by TLR2 contributing to hepatic fibrosis. BMC Med 2021;19:247. [PMID: 34649530 DOI: 10.1186/s12916-021-02085-3] [Reference Citation Analysis]
37 Tran HT, Vong LB, Nishikawa Y, Nagasaki Y. Sorafenib-loaded silica-containing redox nanoparticles for oral anti-liver fibrosis therapy. J Control Release 2022:S0168-3659(22)00196-1. [PMID: 35395328 DOI: 10.1016/j.jconrel.2022.04.002] [Reference Citation Analysis]
38 Hanayama M, Yamamoto Y, Utsunomiya H, Yoshida O, Liu S, Mogi M, Matsuura B, Takeshita E, Ikeda Y, Hiasa Y. The mechanism of increased intestinal palmitic acid absorption and its impact on hepatic stellate cell activation in nonalcoholic steatohepatitis. Sci Rep 2021;11:13380. [PMID: 34183709 DOI: 10.1038/s41598-021-92790-z] [Reference Citation Analysis]
39 Yuan S, Dong M, Zhang H, Jiang X, Yan C, Ye R, Zhou H, Chen L, Lian H, Jin W. Ginsenoside PPD inhibit the activation of HSCs by directly targeting TGFβR1. Int J Biol Macromol 2022;194:556-62. [PMID: 34822828 DOI: 10.1016/j.ijbiomac.2021.11.098] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Cho SS, Lee JH, Kim KM, Park EY, Ku SK, Cho IJ, Yang JH, Ki SH. REDD1 attenuates hepatic stellate cell activation and liver fibrosis via inhibiting of TGF-β/Smad signaling pathway. Free Radic Biol Med 2021;176:246-56. [PMID: 34614448 DOI: 10.1016/j.freeradbiomed.2021.10.002] [Reference Citation Analysis]
41 Abdelhamid AM, Selim A, Zaafan MA. The Hepatoprotective Effect of Piperine Against Thioacetamide-Induced Liver Fibrosis in Mice: The Involvement of miR-17 and TGF-β/Smads Pathways. Front Mol Biosci 2021;8:754098. [PMID: 34778375 DOI: 10.3389/fmolb.2021.754098] [Reference Citation Analysis]
42 Lee HL, Lee J, Cha JH, Cho S, Sung PS, Hur W, Yoon SK, Bae SH. Anti-fibrotic effects of branched-chain amino acids on hepatic stellate cells. Korean J Intern Med 2020. [PMID: 32872742 DOI: 10.3904/kjim.2020.197] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Chen X, Wang Y, Ji S, Sun X, Feng Q, Yu H, Liu C. Hepatoprotective Efficacy and Interventional Mechanism of Qijia Rougan Decoction in Liver Fibrosis. Front Pharmacol 2022;13:911250. [DOI: 10.3389/fphar.2022.911250] [Reference Citation Analysis]
44 Wang T, Zhou X, Kuang G, Jiang R, Guo X, Wu S, Wan J, Yin L. Paeoniflorin modulates oxidative stress, inflammation and hepatic stellate cells activation to alleviate CCl4-induced hepatic fibrosis by upregulation of heme oxygenase-1 in mice. J Pharm Pharmacol 2021;73:338-46. [PMID: 33793876 DOI: 10.1093/jpp/rgaa042] [Reference Citation Analysis]
45 Pivovarova-Ramich O, Loske J, Hornemann S, Markova M, Seebeck N, Rosenthal A, Klauschen F, Castro JP, Buschow R, Grune T, Lange V, Rudovich N, Ouwens DM. Hepatic Wnt1 Inducible Signaling Pathway Protein 1 (WISP-1/CCN4) Associates with Markers of Liver Fibrosis in Severe Obesity. Cells 2021;10:1048. [PMID: 33946738 DOI: 10.3390/cells10051048] [Reference Citation Analysis]
46 Liu S, Murakami E, Nakahara T, Ohya K, Teraoka Y, Makokha GN, Uchida T, Morio K, Fujino H, Ono A, Yamauchi M, Kawaoka T, Miki D, Tsuge M, Hiramatsu A, Abe-Chayama H, Hayes NC, Imamura M, Aikata H, Chayama K. In vitro analysis of hepatic stellate cell activation influenced by transmembrane 6 superfamily 2 polymorphism. Mol Med Rep 2021;23:16. [PMID: 33179077 DOI: 10.3892/mmr.2020.11654] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Cheng J, Chen Z, Zuo G, Cao W. Integrated analysis of differentially expressed genes, differentially methylated genes, and natural compounds in hepatitis C virus-induced cirrhosis. J Int Med Res 2022;50:3000605221074525. [PMID: 35086375 DOI: 10.1177/03000605221074525] [Reference Citation Analysis]
48 Wang F, Zhou J, Chen E. Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis. Front Pharmacol 2022;13:787748. [DOI: 10.3389/fphar.2022.787748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Bu FT, Zhu Y, Chen X, Wang A, Zhang YF, You HM, Yang Y, Yang YR, Huang C, Li J. Circular RNA circPSD3 alleviates hepatic fibrogenesis by regulating the miR-92b-3p/Smad7 axis. Mol Ther Nucleic Acids 2021;23:847-62. [PMID: 33614234 DOI: 10.1016/j.omtn.2021.01.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
50 Chiabotto G, Pasquino C, Camussi G, Bruno S. Molecular Pathways Modulated by Mesenchymal Stromal Cells and Their Extracellular Vesicles in Experimental Models of Liver Fibrosis. Front Cell Dev Biol 2020;8:594794. [PMID: 33425900 DOI: 10.3389/fcell.2020.594794] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
51 Colucci S, Altamura S, Marques O, Dropmann A, Horvat NK, Müdder K, Hammad S, Dooley S, Muckenthaler MU. Liver Sinusoidal Endothelial Cells Suppress Bone Morphogenetic Protein 2 Production in Response to TGFβ Pathway Activation. Hepatology 2021;74:2186-200. [PMID: 33982327 DOI: 10.1002/hep.31900] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Saydmohammed M, Jha A, Mahajan V, Gavlock D, Shun TY, DeBiasio R, Lefever D, Li X, Reese C, Kershaw EE, Yechoor V, Behari J, Soto-Gutierrez A, Vernetti L, Stern A, Gough A, Miedel MT, Lansing Taylor D. Quantifying the progression of non-alcoholic fatty liver disease in human biomimetic liver microphysiology systems with fluorescent protein biosensors. Exp Biol Med (Maywood) 2021;:15353702211009228. [PMID: 33957803 DOI: 10.1177/15353702211009228] [Reference Citation Analysis]
53 Sehgal R, Ilha M, Vaittinen M, Kaminska D, Männistö V, Kärjä V, Tuomainen M, Hanhineva K, Romeo S, Pajukanta P, Pihlajamäki J, de Mello VD. Indole-3-Propionic Acid, a Gut-Derived Tryptophan Metabolite, Associates with Hepatic Fibrosis. Nutrients 2021;13:3509. [PMID: 34684510 DOI: 10.3390/nu13103509] [Reference Citation Analysis]
54 Baptissart M, Bradish CM, Jones BS, Walsh E, Tehrani J, Marrero-Colon V, Mehta S, Jima DD, Oh SH, Diehl AM, Fougeray T, Guillou H, Cowley M. Zac1 and the Imprinted Gene Network program juvenile NAFLD in response to maternal metabolic syndrome. Hepatology 2022. [PMID: 35083765 DOI: 10.1002/hep.32363] [Reference Citation Analysis]
55 Tuleta I, Frangogiannis NG. Diabetic fibrosis. Biochim Biophys Acta Mol Basis Dis 2021;1867:166044. [PMID: 33378699 DOI: 10.1016/j.bbadis.2020.166044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
56 Kanmani P, Kim H. Probiotics counteract the expression of hepatic profibrotic genes via the attenuation of TGF-β/SMAD signaling and autophagy in hepatic stellate cells. PLoS One 2022;17:e0262767. [PMID: 35051234 DOI: 10.1371/journal.pone.0262767] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
57 Bayram B, Owen AR, Dudakovic A, Bettencourt JW, Limberg AK, Morrey ME, Sanchez-Sotelo J, Berry DJ, Kocher JP, van Wijnen AJ, Abdel MP. Elevated Expression of Plasminogen Activator Inhibitor (PAI-1/SERPINE1) is Independent from rs1799889 Genotypes in Arthrofibrosis. Meta Gene 2021;28:100877. [PMID: 33816122 DOI: 10.1016/j.mgene.2021.100877] [Reference Citation Analysis]
58 Machlin JH, Barishansky SJ, Kelsh J, Larmore MJ, Johnson BW, Pritchard MT, Pavone ME, Duncan FE. Fibroinflammatory Signatures Increase with Age in the Human Ovary and Follicular Fluid. Int J Mol Sci 2021;22:4902. [PMID: 34063149 DOI: 10.3390/ijms22094902] [Reference Citation Analysis]
59 Fabregat I, Herrera B, Sánchez A. Editorial Special Issue TGF-beta/BMP Signaling Pathway. Cells 2020;9:E2363. [PMID: 33121103 DOI: 10.3390/cells9112363] [Reference Citation Analysis]
60 Kang H, Seo E, Oh YS, Jun HS. TGF-β activates NLRP3 inflammasome by an autocrine production of TGF-β in LX-2 human hepatic stellate cells. Mol Cell Biochem 2022. [PMID: 35138513 DOI: 10.1007/s11010-022-04369-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Bévant K, Desoteux M, Abdel Wahab AHA, Abdel Wahab SA, Metwally AM, Coulouarn C. DNA Methylation of TGFβ Target Genes: Epigenetic Control of TGFβ Functional Duality in Liver Cancer. Cells 2021;10:2207. [PMID: 34571856 DOI: 10.3390/cells10092207] [Reference Citation Analysis]
62 Qiu C, Liu Y, Huang S, Ning B, He S, Zhong L. Rab31 Promotes Activation of Hepatic Stellate Cells by Accelerating TGF-β Receptor II Complex Endocytosis. The International Journal of Biochemistry & Cell Biology 2022. [DOI: 10.1016/j.biocel.2022.106170] [Reference Citation Analysis]
63 Ho CH, Huang JH, Sun MS, Tzeng IS, Hsu YC, Kuo CY. Wild Bitter Melon Extract Regulates LPS-Induced Hepatic Stellate Cell Activation, Inflammation, Endoplasmic Reticulum Stress, and Ferroptosis. Evid Based Complement Alternat Med 2021;2021:6671129. [PMID: 34239589 DOI: 10.1155/2021/6671129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 An GH, Lee J, Jin X, Chung J, Kim JC, Park JH, Kim M, Han C, Kim JH, Woo DH. Truncated Milk Fat Globule-EGF-like Factor 8 Ameliorates Liver Fibrosis via Inhibition of Integrin-TGFβ Receptor Interaction. Biomedicines 2021;9:1529. [PMID: 34829758 DOI: 10.3390/biomedicines9111529] [Reference Citation Analysis]
65 Liu F, Sun C, Chen Y, Du F, Yang Y, Wu G. Indole-3-propionic Acid-aggravated CCl4-induced Liver Fibrosis via the TGF-β1/Smads Signaling Pathway. J Clin Transl Hepatol 2021;9:917-30. [PMID: 34966655 DOI: 10.14218/JCTH.2021.00032] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Uchida D, Takaki A, Oyama A, Adachi T, Wada N, Onishi H, Okada H. Oxidative Stress Management in Chronic Liver Diseases and Hepatocellular Carcinoma. Nutrients 2020;12:E1576. [PMID: 32481552 DOI: 10.3390/nu12061576] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
67 Wang ZY, Keogh A, Waldt A, Cuttat R, Neri M, Zhu S, Schuierer S, Ruchti A, Crochemore C, Knehr J, Bastien J, Ksiazek I, Sánchez-Taltavull D, Ge H, Wu J, Roma G, Helliwell SB, Stroka D, Nigsch F. Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis. Sci Rep 2021;11:19396. [PMID: 34588551 DOI: 10.1038/s41598-021-98806-y] [Reference Citation Analysis]
68 Gallard C, Lebsir N, Khursheed H, Reungoat E, Plissonnier M, Bré J, Michelet M, Chouik Y, Zoulim F, Pécheur E, Bartosch B, Grigorov B. Heparanase is upregulated by HCV and favors its replication. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2022.01.008] [Reference Citation Analysis]
69 Song X, Shi J, Liu J, Liu Y, Yu Y, Qiu Y, Cao Z, Pan Y, Yuan X, Chu Y, Wu D. Recombinant truncated latency-associated peptide alleviates liver fibrosis in vitro and in vivo via inhibition of TGF-β/Smad pathway. Mol Med 2022;28:80. [PMID: 35842576 DOI: 10.1186/s10020-022-00508-2] [Reference Citation Analysis]
70 Cho HJ, Kim HJ, Lee K, Lasli S, Ung A, Hoffman T, Nasiri R, Bandaru P, Ahadian S, Dokmeci MR, Lee J, Khademhosseini A. Bioengineered Multicellular Liver Microtissues for Modeling Advanced Hepatic Fibrosis Driven Through Non-Alcoholic Fatty Liver Disease. Small 2021;17:e2007425. [PMID: 33690979 DOI: 10.1002/smll.202007425] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Qian H, Chen L. TRIM proteins in fibrosis. Biomed Pharmacother 2021;144:112340. [PMID: 34678729 DOI: 10.1016/j.biopha.2021.112340] [Reference Citation Analysis]
72 Gao Y, Xi B, Li J, Li Z, Xu J, Zhong M, Xu Q, Lian Y, Wei R, Wang L, Cao H, Jin L, Zhang K, Dong J. Scoparone alleviates hepatic fibrosis by inhibiting the TLR-4/NF-κB pathway. J Cell Physiol 2020. [PMID: 33090488 DOI: 10.1002/jcp.30083] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Sanz-garcía C, Fernández-iglesias A, Gracia-sancho J, Arráez-aybar LA, Nevzorova YA, Cubero FJ. The Space of Disse: The Liver Hub in Health and Disease. Livers 2021;1:3-26. [DOI: 10.3390/livers1010002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
74 Hou W, Wu X. Diverse Functions of γδ T Cells in the Progression of Hepatitis B Virus and Hepatitis C Virus Infection. Front Immunol 2020;11:619872. [PMID: 33597951 DOI: 10.3389/fimmu.2020.619872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Sturm L, Roth L, Zoldan K, Schultheiss M, Boettler T, Huber JP, Kaeser R, Thimme R, Bettinger D. Blood reelin in the progression of chronic liver disease. Adv Med Sci 2021;66:148-54. [PMID: 33561810 DOI: 10.1016/j.advms.2021.01.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Tao XM, Li D, Zhang C, Wen GH, Wu C, Xu YY, Kan Y, Lu WP, Ding HY, Yang Y. Salvianolic acid B protects against acute and chronic liver injury by inhibiting Smad2C/L phosphorylation. Exp Ther Med 2021;21:341. [PMID: 33732314 DOI: 10.3892/etm.2021.9772] [Reference Citation Analysis]
77 Gong Y, Yang Y. Activation of Nrf2/AREs-mediated antioxidant signalling, and suppression of profibrotic TGF-β1/Smad3 pathway: a promising therapeutic strategy for hepatic fibrosis - A review. Life Sci 2020;256:117909. [PMID: 32512009 DOI: 10.1016/j.lfs.2020.117909] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
78 Jia F, Hu X, Kimura T, Tanaka N. Impact of Dietary Fat on the Progression of Liver Fibrosis: Lessons from Animal and Cell Studies. Int J Mol Sci 2021;22:10303. [PMID: 34638640 DOI: 10.3390/ijms221910303] [Reference Citation Analysis]
79 Roehlen N, Crouchet E, Baumert TF. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells 2020;9:E875. [PMID: 32260126 DOI: 10.3390/cells9040875] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 24.5] [Reference Citation Analysis]
80 Guo R, Jia X, Ding Z, Wang G, Jiang M, Li B, Chen S, Xia B, Zhang Q, Liu J, Zheng R, Gao Z, Xie X. Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation. Theranostics 2022;12:5220-36. [PMID: 35836819 DOI: 10.7150/thno.71400] [Reference Citation Analysis]
81 Peng W, Zhang S, Zhou W, Zhao X, Wang K, Yue C, Wei X, Pang S, Dong W, Chen S, Chen C, Yang Q, Wang W. Layered Double Hydroxides-Loaded Sorafenib Inhibit Hepatic Stellate Cells Proliferation and Activation In Vitro and Reduce Fibrosis In Vivo. Front Bioeng Biotechnol 2022;10:873971. [PMID: 35711641 DOI: 10.3389/fbioe.2022.873971] [Reference Citation Analysis]
82 Han M, Liao Z, Liu F, Chen X, Zhang B. Modulation of the TGF-β signaling pathway by long noncoding RNA in hepatocellular carcinoma. Biomark Res 2020;8:70. [PMID: 33292618 DOI: 10.1186/s40364-020-00252-x] [Reference Citation Analysis]
83 Huang YJ, Cao J, Lee CY, Wu YM. Umbilical cord blood plasma-derived exosomes as a novel therapy to reverse liver fibrosis. Stem Cell Res Ther 2021;12:568. [PMID: 34772443 DOI: 10.1186/s13287-021-02641-x] [Reference Citation Analysis]
84 Kondo R, Deguchi A, Kawata N, Suzuki Y, Yamamura H. Involvement of TREK1 channels in the proliferation of human hepatic stellate LX-2 cells. Journal of Pharmacological Sciences 2022;148:286-94. [DOI: 10.1016/j.jphs.2022.01.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
85 Yao J, Lin C, Jiang J, Zhang X, Li F, Liu T, Diao H. lncRNA-HEIM Facilitated Liver Fibrosis by Up-Regulating TGF-β Expression in Long-Term Outcome of Chronic Hepatitis B. Front Immunol 2021;12:666370. [PMID: 34168644 DOI: 10.3389/fimmu.2021.666370] [Reference Citation Analysis]
86 Yang B, Luo W, Wang M, Tang Y, Zhu W, Jin L, Wang M, Wang Y, Zhang Y, Zuo W, Huang LJ, Zhao Y, Liang G. Macrophage-specific MyD88 deletion and pharmacological inhibition prevents liver damage in non-alcoholic fatty liver disease via reducing inflammatory response. Biochim Biophys Acta Mol Basis Dis 2022;1868:166480. [PMID: 35811033 DOI: 10.1016/j.bbadis.2022.166480] [Reference Citation Analysis]
87 Yu S, Ericson M, Fanjul A, Erion DM, Paraskevopoulou M, Smith EN, Cole B, Feaver R, Holub C, Gavva N, Horman SR, Huang J. Genome-wide CRISPR Screening to Identify Drivers of TGF-β-Induced Liver Fibrosis in Human Hepatic Stellate Cells. ACS Chem Biol 2022;17:918-29. [PMID: 35274923 DOI: 10.1021/acschembio.2c00006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Takeuchi M, Sakasai-Sakai A, Takata T, Takino JI, Koriyama Y, Kikuchi C, Furukawa A, Nagamine K, Hori T, Matsunaga T. Intracellular Toxic AGEs (TAGE) Triggers Numerous Types of Cell Damage. Biomolecules 2021;11:387. [PMID: 33808036 DOI: 10.3390/biom11030387] [Reference Citation Analysis]
89 Leilei L, Xue S, Yan L, Yuyuan L, Ying W, Wenke Q, Xuesong Y, Ming L. PM2.5-exposed hepatocytes induce hepatic stellate cells activation by releasing TGF-β1. Biochem Biophys Res Commun 2021;569:125-31. [PMID: 34243068 DOI: 10.1016/j.bbrc.2021.07.002] [Reference Citation Analysis]
90 Li Z, Chiang YP, He M, Worgall TS, Zhou H, Jiang XC. Liver sphingomyelin synthase 1 deficiency causes steatosis, steatohepatitis, fibrosis, and tumorigenesis: An effect of glucosylceramide accumulation. iScience 2021;24:103449. [PMID: 34927020 DOI: 10.1016/j.isci.2021.103449] [Reference Citation Analysis]
91 Lam HYP, Liang TR, Lan YC, Chang KC, Cheng PC, Peng SY. Antifibrotic and anthelminthic effect of casticin on Schistosoma mansoni-infected BALB/c mice. J Microbiol Immunol Infect 2021:S1684-1182(21)00086-4. [PMID: 34167886 DOI: 10.1016/j.jmii.2021.03.017] [Reference Citation Analysis]
92 Zeweil MM, Sadek KM, Elsadek MF, Mahmoud SF, Ahmed BM, Khafaga AF. Sidr honey abrogates the oxidative stress and downregulates the hyaluronic acid concentration and gene expression of TGF-β1 and COL1a1 in rat model of thioacetamide-induced hepatic fibrosis. Anim Sci J 2020;91:e13434. [PMID: 32696560 DOI: 10.1111/asj.13434] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
93 Dai W, Qin Q, Li Z, Lin L, Li R, Fang Z, Han Y, Mu W, Ren L, Liu T, Zhan X, Xiao X, Bai Z. Curdione and Schisandrin C Synergistically Reverse Hepatic Fibrosis via Modulating the TGF-β Pathway and Inhibiting Oxidative Stress. Front Cell Dev Biol 2021;9:763864. [PMID: 34858986 DOI: 10.3389/fcell.2021.763864] [Reference Citation Analysis]
94 Li X, Li H, Zhang S, Zhang R, Li J, Wei Y, Yang C, Zhang F, Zhou H. Protective effect of Idelalisib on carbon tetrachloride-induced liver fibrosis via microRNA-124-3P/phosphatidylinositol-3-hydroxykinase signalling pathway. J Cell Mol Med 2021. [PMID: 34747105 DOI: 10.1111/jcmm.17039] [Reference Citation Analysis]
95 Wang H, Wang Z, Wang Y, Li X, Yang W, Wei S, Shi C, Qiu J, Ni M, Rao J, Cheng F. miRNA-130b-5p promotes hepatic stellate cell activation and the development of liver fibrosis by suppressing SIRT4 expression. J Cell Mol Med 2021;25:7381-94. [PMID: 34272822 DOI: 10.1111/jcmm.16766] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
96 Won SM, Park E, Jeong JJ, Ganesan R, Gupta H, Gebru YA, Sharma S, Kim DJ, Suk KT. The Gut Microbiota-Derived Immune Response in Chronic Liver Disease. Int J Mol Sci 2021;22:8309. [PMID: 34361075 DOI: 10.3390/ijms22158309] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Huang Q, Xu J, Ge Y, Shi Y, Wang F, Zhu M. NR4A1 inhibits the epithelial–mesenchymal transition of hepatic stellate cells: Involvement of TGF-β–Smad2/3/4–ZEB signaling. Open Life Sciences 2022;17:447-54. [DOI: 10.1515/biol-2022-0047] [Reference Citation Analysis]
98 Xu X, Zeng X, Li R, Feng J, Huang D, Huang Y. [Mechanism of hepatocyte mitochondrial NDUFA13 deficiency-induced liver fibrogenesis: the role of abnormal hepatic stellate cell activation]. Nan Fang Yi Ke Da Xue Xue Bao 2021;41:529-35. [PMID: 33963711 DOI: 10.12122/j.issn.1673-4254.2021.04.07] [Reference Citation Analysis]
99 Ai Y, Shi W, Zuo X, Sun X, Chen Y, Wang Z, Li R, Song X, Dai W, Mu W, Ding K, Li Z, Li Q, Xiao X, Zhan X, Bai Z. The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis Via Modulating Multiple Signaling Pathways in Mice. Front Pharmacol 2021;12:655531. [PMID: 34149411 DOI: 10.3389/fphar.2021.655531] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
100 Castro-Gil MP, Sánchez-Rodríguez R, Torres-Mena JE, López-Torres CD, Quintanar-Jurado V, Gabiño-López NB, Villa-Treviño S, Del-Pozo-Jauner L, Arellanes-Robledo J, Pérez-Carreón JI. Enrichment of progenitor cells by 2-acetylaminofluorene accelerates liver carcinogenesis induced by diethylnitrosamine in vivo. Mol Carcinog 2021;60:377-90. [PMID: 33765333 DOI: 10.1002/mc.23298] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
101 Sánchez PS, Rigual MDM, Djouder N. Inflammatory and Non-Inflammatory Mechanisms Controlling Cirrhosis Development. Cancers (Basel) 2021;13:5045. [PMID: 34680192 DOI: 10.3390/cancers13205045] [Reference Citation Analysis]
102 Lei L, Ei Mourabit H, Housset C, Cadoret A, Lemoinne S. Role of Angiogenesis in the Pathogenesis of NAFLD. J Clin Med 2021;10:1338. [PMID: 33804956 DOI: 10.3390/jcm10071338] [Reference Citation Analysis]
103 Wang C, Li Y, Li H, Zhang Y, Ying Z, Wang X, Zhang T, Zhang W, Fan Z, Li X, Ma J, Pan X. Disruption of FGF Signaling Ameliorates Inflammatory Response in Hepatic Stellate Cells. Front Cell Dev Biol 2020;8:601. [PMID: 32793588 DOI: 10.3389/fcell.2020.00601] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
104 Mahmoudi A, Jamialahmadi T, Johnston TP, Sahebkar A. Impact of fenofibrate on NAFLD/NASH: A genetic perspective. Drug Discov Today 2022:S1359-6446(22)00194-5. [PMID: 35569762 DOI: 10.1016/j.drudis.2022.05.007] [Reference Citation Analysis]
105 Qian LL, Ji JJ, Jiang Y, Guo JQ, Wu Y, Yang Z, Ma G, Yao YY. Serpina3c deficiency induced necroptosis promotes non‐alcoholic fatty liver disease through β‐catenin/Foxo1/TLR4 signaling. The FASEB Journal 2022;36. [DOI: 10.1096/fj.202101345rrr] [Reference Citation Analysis]
106 Gu L, Zhang F, Wu J, Zhuge Y. Nanotechnology in Drug Delivery for Liver Fibrosis. Front Mol Biosci 2022;8:804396. [DOI: 10.3389/fmolb.2021.804396] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Wang Y, Li Y, Zhang H, Zhu L, Zhong J, Zeng J, Meng C, Wu J, Wang T, Shi R, Yuan W, Jiang J, Liu P, Ma Y. Pharmacokinetics-based comprehensive strategy to identify multiple effective components in Huangqi decoction against liver fibrosis. Phytomedicine 2021;84:153513. [PMID: 33647776 DOI: 10.1016/j.phymed.2021.153513] [Reference Citation Analysis]
108 Benedicto A, García-Kamiruaga I, Arteta B. Neuropilin-1: A feasible link between liver pathologies and COVID-19. World J Gastroenterol 2021; 27(24): 3516-3529 [PMID: 34239266 DOI: 10.3748/wjg.v27.i24.3516] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
109 Ströbel S, Kostadinova R, Fiaschetti-Egli K, Rupp J, Bieri M, Pawlowska A, Busler D, Hofstetter T, Sanchez K, Grepper S, Thoma E. A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates. Sci Rep 2021;11:22765. [PMID: 34815444 DOI: 10.1038/s41598-021-01951-7] [Reference Citation Analysis]
110 Messner CJ, Babrak L, Titolo G, Caj M, Miho E, Suter-Dick L. Single Cell Gene Expression Analysis in a 3D Microtissue Liver Model Reveals Cell Type-Specific Responses to Pro-Fibrotic TGF-β1 Stimulation. Int J Mol Sci 2021;22:4372. [PMID: 33922101 DOI: 10.3390/ijms22094372] [Reference Citation Analysis]
111 Yan Z, Da Q, Li Z, Lin Q, Yi J, Su Y, Yu G, Ren Q, Liu X, Lin Z, Qu J, Yin W, Liu J. Inhibition of NEK7 Suppressed Hepatocellular Carcinoma Progression by Mediating Cancer Cell Pyroptosis. Front Oncol 2022;12:812655. [PMID: 35223495 DOI: 10.3389/fonc.2022.812655] [Reference Citation Analysis]
112 Santhakumar C, Gane EJ, Liu K, Mccaughan GW. Current perspectives on the tumor microenvironment in hepatocellular carcinoma. Hepatol Int 2020;14:947-57. [DOI: 10.1007/s12072-020-10104-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
113 Kumar S, Duan Q, Wu R, Harris EN, Su Q. Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis. Adv Drug Deliv Rev 2021;176:113869. [PMID: 34280515 DOI: 10.1016/j.addr.2021.113869] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 17.0] [Reference Citation Analysis]
114 Chen PJ, Kuo LM, Wu YH, Chang YC, Lai KH, Hwang TL. BAY 41-2272 Attenuates CTGF Expression via sGC/cGMP-Independent Pathway in TGFβ1-Activated Hepatic Stellate Cells. Biomedicines 2020;8:E330. [PMID: 32899801 DOI: 10.3390/biomedicines8090330] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
115 Zanotti S, Boot GF, Coto-llerena M, Gallon J, Hess GF, Soysal SD, Kollmar O, Ng CKY, Piscuoglio S. The Role of Chronic Liver Diseases in the Emergence and Recurrence of Hepatocellular Carcinoma: An Omics Perspective. Front Med 2022;9:888850. [DOI: 10.3389/fmed.2022.888850] [Reference Citation Analysis]
116 O'Brien A, Zhou T, White T, Medford A, Chen L, Kyritsi K, Wu N, Childs J, Stiles D, Ceci L, Chakraborty S, Ekser B, Baiocchi L, Carpino G, Gaudio E, Wu C, Kennedy L, Francis H, Alpini G, Glaser S. FGF1 Signaling Modulates Biliary Injury and Liver Fibrosis in the Mdr2-/- Mouse Model of Primary Sclerosing Cholangitis. Hepatol Commun 2022. [PMID: 35271760 DOI: 10.1002/hep4.1909] [Reference Citation Analysis]
117 Zhou J, Zhang X, Wan L, Yu J, Li T, Lu Z, Fang N, Sun L, Ye F. Zi Qi Decoction Alleviates Liver Fibrosis by Inhibiting the Toll-Like Receptor 4 (TLR4)-Related Nuclear Factor kappa b (NF-κB) and Mitogen-Activated Protein Kinase (MAPK) Signaling Pathways. Med Sci Monit 2021;27:e929438. [PMID: 33850093 DOI: 10.12659/MSM.929438] [Reference Citation Analysis]
118 Chen L, Kong D, Xia S, Wang F, Li Z, Zhang F, Zheng S. Crosstalk Between Autophagy and Innate Immunity: A Pivotal Role in Hepatic Fibrosis. Front Pharmacol 2022;13:891069. [PMID: 35656309 DOI: 10.3389/fphar.2022.891069] [Reference Citation Analysis]
119 Yu Q, Cheng P, Wu J, Guo C. PPARγ/NF-κB and TGF-β1/Smad pathway are involved in the anti-fibrotic effects of levo-tetrahydropalmatine on liver fibrosis. J Cell Mol Med 2021;25:1645-60. [PMID: 33438347 DOI: 10.1111/jcmm.16267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
120 Yang JH, Ku SK, Cho ILJ, Lee JH, Na CS, Ki SH. Neoagarooligosaccharide Protects against Hepatic Fibrosis via Inhibition of TGF-β/Smad Signaling Pathway. Int J Mol Sci 2021;22:2041. [PMID: 33670808 DOI: 10.3390/ijms22042041] [Reference Citation Analysis]
121 Guo J, Liu W, Zeng Z, Lin J, Zhang X, Chen L. Tgfb3 and Mmp13 regulated the initiation of liver fibrosis progression as dynamic network biomarkers. J Cell Mol Med 2021;25:867-79. [PMID: 33269546 DOI: 10.1111/jcmm.16140] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
122 Assadiasl S, Mooney N, Nicknam MH. Cytokines in Liver Transplantation. Cytokine 2021;148:155705. [PMID: 34564024 DOI: 10.1016/j.cyto.2021.155705] [Reference Citation Analysis]
123 Katsarou A, Moustakas II, Pyrina I, Lembessis P, Koutsilieris M, Chatzigeorgiou A. Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease. World J Gastroenterol 2020; 26(17): 1993-2011 [PMID: 32536770 DOI: 10.3748/wjg.v26.i17.1993] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 34] [Article Influence: 18.5] [Reference Citation Analysis]
124 Ezhilarasan D. Relaxin in hepatic fibrosis: What is known and where to head? Biochimie 2021;187:144-51. [PMID: 34102254 DOI: 10.1016/j.biochi.2021.06.001] [Reference Citation Analysis]
125 Fu K, Wang C, Ma C, Zhou H, Li Y. The Potential Application of Chinese Medicine in Liver Diseases: A New Opportunity. Front Pharmacol 2021;12:771459. [PMID: 34803712 DOI: 10.3389/fphar.2021.771459] [Reference Citation Analysis]
126 Li T, Tuo B. Pathophysiology of hepatic Na+/H+ exchange (Review). Exp Ther Med 2020;20:1220-9. [PMID: 32742358 DOI: 10.3892/etm.2020.8888] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
127 Damiris K, Tafesh ZH, Pyrsopoulos N. Efficacy and safety of anti-hepatic fibrosis drugs. World J Gastroenterol 2020; 26(41): 6304-6321 [PMID: 33244194 DOI: 10.3748/wjg.v26.i41.6304] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
128 Maldonado H, Hagood JS. Cooperative signaling between integrins and growth factor receptors in fibrosis. J Mol Med 2021;99:213-24. [DOI: 10.1007/s00109-020-02026-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
129 Wang YH, Suk FM, Liu CL, Chen TL, Twu YC, Hsu MH, Liao YJ. Antifibrotic Effects of a Barbituric Acid Derivative on Liver Fibrosis by Blocking the NF-κB Signaling Pathway in Hepatic Stellate Cells. Front Pharmacol 2020;11:388. [PMID: 32296336 DOI: 10.3389/fphar.2020.00388] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
130 Gonzalez-Sanchez E, Vaquero J, Férnandez-Barrena MG, Lasarte JJ, Avila MA, Sarobe P, Reig M, Calvo M, Fabregat I. The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma? Cancers (Basel) 2021;13:3248. [PMID: 34209646 DOI: 10.3390/cancers13133248] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Bestion E, Jilkova ZM, Mège JL, Novello M, Kurma K, Pour STA, Lalmanach G, Vanderlynden L, Fizanne L, Bassissi F, Rachid M, Tracz J, Boursier J, Courcambeck J, Serdjebi C, Ansaldi C, Decaens T, Halfon P, Brun S. GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition. Ther Adv Chronic Dis 2020;11:2040622320942042. [PMID: 32728410 DOI: 10.1177/2040622320942042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
132 Mostafa TM, El-Azab GA, Badra GA, Abdelwahed AS, Elsayed AA. Effect of Candesartan and Ramipril on Liver Fibrosis in Patients with Chronic Hepatitis C Viral Infection: A Randomized Controlled Prospective Study. Curr Ther Res Clin Exp 2021;95:100654. [PMID: 34925649 DOI: 10.1016/j.curtheres.2021.100654] [Reference Citation Analysis]
133 Guo CJ, Pan Q, Ma X. lncRNA NONRATT013819.2 promotes transforming growth factor-β1-induced myofibroblastic transition of hepatic stellate cells by miR24-3p/lox. Open Med (Wars) 2022;17:661-75. [PMID: 35434372 DOI: 10.1515/med-2022-0460] [Reference Citation Analysis]
134 Kyritsi K, Kennedy L, Meadows V, Hargrove L, Demieville J, Pham L, Sybenga A, Kundu D, Cerritos K, Meng F, Alpini G, Francis H. Mast Cells Induce Ductular Reaction Mimicking Liver Injury in Mice Through Mast Cell-Derived Transforming Growth Factor Beta 1 Signaling. Hepatology 2021;73:2397-410. [PMID: 32761972 DOI: 10.1002/hep.31497] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
135 Song Y, Kim S, Heo J, Shum D, Lee SY, Lee M, Kim AR, Seo HR. Identification of hepatic fibrosis inhibitors through morphometry analysis of a hepatic multicellular spheroids model. Sci Rep 2021;11:10931. [PMID: 34035369 DOI: 10.1038/s41598-021-90263-x] [Reference Citation Analysis]
136 Cheng R, Xu H, Hong Y. miR221 regulates TGF-β1-induced HSC activation through inhibiting autophagy by directly targeting LAMP2. Mol Med Rep 2021;24:777. [PMID: 34498712 DOI: 10.3892/mmr.2021.12417] [Reference Citation Analysis]
137 Kim SM, Hur WH, Kang BY, Lee SW, Roh PR, Park DJ, Sung PS, Yoon SK. Death-Associated Protein 6 (Daxx) Alleviates Liver Fibrosis by Modulating Smad2 Acetylation. Cells 2021;10:1742. [PMID: 34359912 DOI: 10.3390/cells10071742] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
138 Zhou MY, Cheng ML, Huang T, Hu RH, Zou GL, Li H, Zhang BF, Zhu JJ, Liu YM, Liu Y, Zhao XK. Transforming growth factor beta-1 upregulates glucose transporter 1 and glycolysis through canonical and noncanonical pathways in hepatic stellate cells. World J Gastroenterol 2021; 27(40): 6908-6926 [PMID: 34790014 DOI: 10.3748/wjg.v27.i40.6908] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
139 Wang E, Liao Z, Wang L, Liao Y, Xu X, Liu P, Wang X, Hou J, Jiang H, Wu X, Chen X. A combination of pirfenidone and TGF-β inhibition mitigates cystic echinococcosis-associated hepatic injury. Parasitology 2021;148:767-78. [PMID: 33583470 DOI: 10.1017/S0031182021000287] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
140 Sufleţel RT, Melincovici CS, Gheban BA, Toader Z, Mihu CM. Hepatic stellate cells - from past till present: morphology, human markers, human cell lines, behavior in normal and liver pathology. Rom J Morphol Embryol 2020;61:615-42. [PMID: 33817704 DOI: 10.47162/RJME.61.3.01] [Reference Citation Analysis]
141 Dong HN, Park SY, Le CT, Choi DH, Cho EH. Irisin Regulates the Functions of Hepatic Stellate Cells. Endocrinol Metab (Seoul) 2020;35:647-55. [PMID: 32981307 DOI: 10.3803/EnM.2020.658] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
142 Ortiz C, Schierwagen R, Schaefer L, Klein S, Trepat X, Trebicka J. Extracellular Matrix Remodeling in Chronic Liver Disease. Curr Tissue Microenviron Rep 2021;:1-12. [PMID: 34337431 DOI: 10.1007/s43152-021-00030-3] [Reference Citation Analysis]
143 Liu S, Han D, Xu C, Yang F, Li Y, Zhang K, Zhao X, Zhang J, Lu T, Lu S, Shi C, Zhang R, Yang AG, Zhao A, Qin W, Yang B, Wen W. Antibody-drug conjugates targeting CD248 inhibits liver fibrosis through specific killing on myofibroblasts. Mol Med 2022;28:37. [PMID: 35317721 DOI: 10.1186/s10020-022-00460-1] [Reference Citation Analysis]
144 Shukry M, Alotaibi SS, Albogami SM, Fathallah N, Farrag F, Dawood MAO, Gewaily MS. Garlic Alleviates the Injurious Impact of Cyclosporine-A in Male Rats through Modulation of Fibrogenic and Steroidogenic Genes. Animals (Basel) 2020;11:E64. [PMID: 33396300 DOI: 10.3390/ani11010064] [Reference Citation Analysis]
145 Salehipour Bavarsad S, Jalali MT, Bijan Nejad D, Alypoor B, Babaahmadi Rezaei H, Mohammadtaghvaei N. TGFβ1-Pretreated Exosomes of Wharton Jelly Mesenchymal Stem Cell as a Therapeutic Strategy for Improving Liver Fibrosis. Hepat Mon 2022;22. [DOI: 10.5812/hepatmon-123416] [Reference Citation Analysis]
146 Kim J, Kang W, Kang SH, Park SH, Kim JY, Yang S, Ha SY, Paik YH. Proline-rich tyrosine kinase 2 mediates transforming growth factor-beta-induced hepatic stellate cell activation and liver fibrosis. Sci Rep. 2020;10:21018. [PMID: 33273492 DOI: 10.1038/s41598-020-78056-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
147 Khanam A, Chua JV, Kottilil S. Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression. Int J Mol Sci 2021;22:5497. [PMID: 34071064 DOI: 10.3390/ijms22115497] [Reference Citation Analysis]
148 Hsu C, Huang Y, Lin S, Hsu C. AXL and MET in Hepatocellular Carcinoma: A Systematic Literature Review. Liver Cancer. [DOI: 10.1159/000520501] [Reference Citation Analysis]
149 Liu ZL, Liu JH, Staiculescu D, Chen J. Combination of molecularly targeted therapies and immune checkpoint inhibitors in the new era of unresectable hepatocellular carcinoma treatment. Ther Adv Med Oncol 2021;13:17588359211018026. [PMID: 34104226 DOI: 10.1177/17588359211018026] [Reference Citation Analysis]
150 Quenum AJI, Shukla A, Rexhepi F, Cloutier M, Ghosh A, Kufer TA, Ramanathan S, Ilangumaran S. NLRC5 Deficiency Deregulates Hepatic Inflammatory Response but Does Not Aggravate Carbon Tetrachloride-Induced Liver Fibrosis. Front Immunol 2021;12:749646. [PMID: 34712238 DOI: 10.3389/fimmu.2021.749646] [Reference Citation Analysis]
151 Zimny S, Koob D, Li J, Wimmer R, Schiergens T, Nagel J, Reiter FP, Denk G, Hohenester S. Hydrophobic Bile Salts Induce Pro-Fibrogenic Proliferation of Hepatic Stellate Cells through PI3K p110 Alpha Signaling. Cells 2022;11:2344. [DOI: 10.3390/cells11152344] [Reference Citation Analysis]
152 Chang Y, Li H. Hepatic Antifibrotic Pharmacotherapy: Are We Approaching Success? J Clin Transl Hepatol 2020;8:222-9. [PMID: 32832403 DOI: 10.14218/JCTH.2020.00026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
153 Heo JH, Lee SR, Jo SL, Ko JW, Kwon HJ, Hong EJ. Hepatic LKB1 Reduces the Progression of Non-Alcoholic Fatty Liver Disease via Genomic Androgen Receptor Signaling. Int J Mol Sci 2021;22:7904. [PMID: 34360667 DOI: 10.3390/ijms22157904] [Reference Citation Analysis]
154 Leilei L, Wenke Q, Yuyuan L, Sihang L, Xue S, Weiqiang C, Lianbao Y, Ying W, Yan L, Ming L. Oleanolic acid-loaded nanoparticles attenuate activation of hepatic stellate cells via suppressing TGF-β1 and oxidative stress in PM2.5-exposed hepatocytes. Toxicol Appl Pharmacol 2022;:115891. [PMID: 35077758 DOI: 10.1016/j.taap.2022.115891] [Reference Citation Analysis]
155 Li J, Dong S, Ye M, Peng G, Luo J, Wang C, Wang J, Zhao Q, Chang Y, Wang H. MicroRNA-489-3p Represses Hepatic Stellate Cells Activation by Negatively Regulating the JAG1/Notch3 Signaling Pathway. Dig Dis Sci 2021;66:143-50. [PMID: 32144602 DOI: 10.1007/s10620-020-06174-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
156 Wang HH, Huang JH, Sue MH, Ho WC, Hsu YH, Chang KC, Chang MS. Interleukin-24 protects against liver injury in mouse models. EBioMedicine 2021;64:103213. [PMID: 33508745 DOI: 10.1016/j.ebiom.2021.103213] [Reference Citation Analysis]
157 Cierpka R, Weiskirchen R, Asimakopoulos A. Perilipin 5 Ameliorates Hepatic Stellate Cell Activation via SMAD2/3 and SNAIL Signaling Pathways and Suppresses STAT3 Activation. Cells 2021;10:2184. [PMID: 34571833 DOI: 10.3390/cells10092184] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
158 Li Z, Wang Z, Dong F, Shi W, Dai W, Zhao J, Li Q, Fang ZE, Ren L, Liu T, Wei Z, Mou W, Lin L, Yang Y, Xiao X, Ma L, Bai Z. Germacrone Attenuates Hepatic Stellate Cells Activation and Liver Fibrosis via Regulating Multiple Signaling Pathways. Front Pharmacol 2021;12:745561. [PMID: 34675811 DOI: 10.3389/fphar.2021.745561] [Reference Citation Analysis]
159 Barry AE, Baldeosingh R, Lamm R, Patel K, Zhang K, Dominguez DA, Kirton KJ, Shah AP, Dang H. Hepatic Stellate Cells and Hepatocarcinogenesis. Front Cell Dev Biol 2020;8:709. [PMID: 32850829 DOI: 10.3389/fcell.2020.00709] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
160 Tavakoli S, Ghaderi Jafarbeigloo HR, Shariati A, Jahangiryan A, Jadidi F, Jadidi Kouhbanani MA, Hassanzadeh A, Zamani M, Javidi K, Naimi A. Mesenchymal stromal cells; a new horizon in regenerative medicine. J Cell Physiol. 2020;235:9185-9210. [PMID: 32452052 DOI: 10.1002/jcp.29803] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
161 Sharma A. Lipid droplets associated perilipins protein insights into finding a therapeutic target approach to cure non-alcoholic fatty liver disease (NAFLD). Futur J Pharm Sci 2022;8. [DOI: 10.1186/s43094-021-00395-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
162 Shi Y, Wang S, Zhang W, Zhu Y, Fan Z, Huang Y, Li F, Yang R. Bone marrow mesenchymal stem cells facilitate diabetic wound healing through the restoration of epidermal cell autophagy via the HIF-1α/TGF-β1/SMAD pathway. Stem Cell Res Ther 2022;13:314. [PMID: 35841007 DOI: 10.1186/s13287-022-02996-9] [Reference Citation Analysis]
163 Baghaei K, Mazhari S, Tokhanbigli S, Parsamanesh G, Alavifard H, Schaafsma D, Ghavami S. Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis. Drug Discov Today 2021:S1359-6446(21)00562-6. [PMID: 34952225 DOI: 10.1016/j.drudis.2021.12.012] [Reference Citation Analysis]
164 Heyens LJM, Busschots D, Koek GH, Robaeys G, Francque S. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment. Front Med (Lausanne) 2021;8:615978. [PMID: 33937277 DOI: 10.3389/fmed.2021.615978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
165 Muñoz-Ortega M, Macías-Segura N, Ventura-Juárez J, Ávila-Blanco ME, Ponce-Damian LD, González-Blas D, Sánchez-Alemán E, Quintanar-Stephano A. Recovery from Liver Failure and Fibrosis in a Rat Portacaval Anastomosis Model after Neurointermediate Pituitary Lobectomy. J Immunol Res 2021;2021:5529784. [PMID: 34926704 DOI: 10.1155/2021/5529784] [Reference Citation Analysis]